Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
K-TEC, operating primarily as K-Laser USA, is a leading medical technology company specializing in advanced Class IV laser therapy systems. The company's primary focus is on photobiomodulation (PBM) therapy, which utilizes specific wavelengths of light to stimulate cellular regeneration and accelerate the body's natural healing processes. Their flagship products, including the K-Laser Platinum series, are widely used by healthcare professionals in sports medicine, orthopedics, and physical therapy to manage chronic and acute pain, reduce inflammation, and improve tissue repair. K-TEC's technology is distinguished by its multi-wavelength delivery and high power output, allowing for deeper tissue penetration and more efficient treatment times compared to traditional cold lasers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ktec.